Form 4 for NUTX Nutex Health Inc.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001062993-22-023884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-14 | 2022-12-12+ | NUTX | Young Matthew Stephen | Dir | S - Sale | $2.17 | -169.4K | 41.96M | -0.4% | -$367.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-12 | S | D | 125,498 | $2.21 | 42,008,712 | D | — | — | (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.445, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. (F3) Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier. |
| 2 | Common | Class A Common Stock | 2022-12-13 | S | D | 43,880 | $2.06 | 41,964,832 | D | — | — | (F4) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.12, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2. (F3) Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier. |